Transitional cell carcinoma: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
{{SCC}} | {{SCC}} | ||
==[[Transitional cell carcinoma overview|Overview]]== | |||
==[[Transitional cell carcinoma historical perspective|Historical Perspective]]== | |||
==[[Transitional cell carcinoma classification|Classifications]]== | |||
==[[Transitional cell carcinoma pathophysiology|Pathophysiology]]== | |||
==[[Transitional cell carcinoma causes|Causes]]== | |||
==[[Transitional cell carcinoma differential diagnosis|Differentiating Transitional cell carcinoma from other Disorders]]== | |||
==[[Transitional cell carcinoma epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Transitional cell carcinoma risk factors|Risk Factors]]== | |||
==[[Transitional cell carcinoma screening|Screening]]== | |||
==[[Transitional cell carcinoma natural history, complications and prognosis|Natural History, Complications, and Prognosis]]== | |||
==Diagnosis== | |||
[[Transitional cell carcinoma history and symptoms|History and Symptoms]] | [[Transitional cell carcinoma physical examination|Physical Examination]] | [[Transitional cell carcinoma laboratory findings|Laboratory Findings]] | [[Transitional cell carcinoma staging|Staging]] | [[Transitional cell carcinoma cystoscopy and bladder biopsy|Cystoscopy and Bladder Biopsy]] | [[Transitional cell carcinoma chest x ray|X Rays]] | [[Transitional cell carcinoma CT|CT]] | [[Transitional cell carcinoma MRI|MRI]] | [[Transitional cell carcinoma ultrasound|Ultrasound]] | [[Transitional cell carcinoma other imaging findings|Other Imaging Findings]] | [[Transitional cell carcinoma other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Transitional cell carcinoma medical therapy|Medical Therapy]] | [[Transitional cell carcinoma surgery|Surgical]] | [[Transitional cell carcinoma primary prevention|Primary Prevention]] | [[Transitional cell carcinoma secondary prevention|Secondary Prevention]] | [[Transitional cell carcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Transitional cell carcinoma future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Transitional cell carcinoma case study one|Case #1]] | |||
==References== | ==References== | ||
Revision as of 14:06, 11 September 2012
| Transitional cell carcinoma | |
| ICD-O: | 8120-8130 |
|---|---|
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma |
For patient information page click here
Steven C. Campbell, M.D., Ph.D.
Overview
Historical Perspective
Classifications
Pathophysiology
Causes
Differentiating Transitional cell carcinoma from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Staging | Cystoscopy and Bladder Biopsy | X Rays | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgical | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies